A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-04-01
|
| Series: | Cancer Communications |
| Online Access: | https://doi.org/10.1002/cac2.12401 |
| _version_ | 1797847967928942592 |
|---|---|
| author | Tatiana Shaurova Lingyue Yan Yafei Su Laurie James Rich Vui King Vincent‐Chong Hannah Calkins Saraswati Pokharel Martin Petkovich Mukund Seshadri Yun Wu Pamela Anne Hershberger |
| author_facet | Tatiana Shaurova Lingyue Yan Yafei Su Laurie James Rich Vui King Vincent‐Chong Hannah Calkins Saraswati Pokharel Martin Petkovich Mukund Seshadri Yun Wu Pamela Anne Hershberger |
| author_sort | Tatiana Shaurova |
| collection | DOAJ |
| first_indexed | 2024-04-09T18:19:49Z |
| format | Article |
| id | doaj.art-4c6eb2db26ac4ab8ba970459644a9b28 |
| institution | Directory Open Access Journal |
| issn | 2523-3548 |
| language | English |
| last_indexed | 2024-04-09T18:19:49Z |
| publishDate | 2023-04-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cancer Communications |
| spelling | doaj.art-4c6eb2db26ac4ab8ba970459644a9b282023-04-12T08:18:43ZengWileyCancer Communications2523-35482023-04-0143450350710.1002/cac2.12401A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancerTatiana Shaurova0Lingyue Yan1Yafei Su2Laurie James Rich3Vui King Vincent‐Chong4Hannah Calkins5Saraswati Pokharel6Martin Petkovich7Mukund Seshadri8Yun Wu9Pamela Anne Hershberger10Department of Pharmacology and Therapeutics Roswell Park Comprehensive Cancer Center Buffalo New York USADepartment of Biomedical Engineering University at Buffalo the State University of New York Buffalo New York USADepartment of Biomedical Engineering University at Buffalo the State University of New York Buffalo New York USACell Stress and Biophysical Oncology Graduate Program Roswell Park Comprehensive Cancer Center Buffalo New York USADepartment of Oral Oncology Roswell Park Comprehensive Cancer Center Buffalo New York USADepartment of Pharmacology and Therapeutics Roswell Park Comprehensive Cancer Center Buffalo New York USADepartment of Pathology Roswell Park Comprehensive Cancer Center Buffalo New York USACancer Research Institute School of Medicine Queens University Kingston Ontario CanadaDepartment of Oral Oncology Roswell Park Comprehensive Cancer Center Buffalo New York USADepartment of Biomedical Engineering University at Buffalo the State University of New York Buffalo New York USADepartment of Pharmacology and Therapeutics Roswell Park Comprehensive Cancer Center Buffalo New York USAhttps://doi.org/10.1002/cac2.12401 |
| spellingShingle | Tatiana Shaurova Lingyue Yan Yafei Su Laurie James Rich Vui King Vincent‐Chong Hannah Calkins Saraswati Pokharel Martin Petkovich Mukund Seshadri Yun Wu Pamela Anne Hershberger A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer Cancer Communications |
| title | A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer |
| title_full | A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer |
| title_fullStr | A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer |
| title_full_unstemmed | A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer |
| title_short | A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer |
| title_sort | nanotherapeutic strategy to target drug tolerant cells and overcome egfr tyrosine kinase inhibitor resistance in lung cancer |
| url | https://doi.org/10.1002/cac2.12401 |
| work_keys_str_mv | AT tatianashaurova ananotherapeuticstrategytotargetdrugtolerantcellsandovercomeegfrtyrosinekinaseinhibitorresistanceinlungcancer AT lingyueyan ananotherapeuticstrategytotargetdrugtolerantcellsandovercomeegfrtyrosinekinaseinhibitorresistanceinlungcancer AT yafeisu ananotherapeuticstrategytotargetdrugtolerantcellsandovercomeegfrtyrosinekinaseinhibitorresistanceinlungcancer AT lauriejamesrich ananotherapeuticstrategytotargetdrugtolerantcellsandovercomeegfrtyrosinekinaseinhibitorresistanceinlungcancer AT vuikingvincentchong ananotherapeuticstrategytotargetdrugtolerantcellsandovercomeegfrtyrosinekinaseinhibitorresistanceinlungcancer AT hannahcalkins ananotherapeuticstrategytotargetdrugtolerantcellsandovercomeegfrtyrosinekinaseinhibitorresistanceinlungcancer AT saraswatipokharel ananotherapeuticstrategytotargetdrugtolerantcellsandovercomeegfrtyrosinekinaseinhibitorresistanceinlungcancer AT martinpetkovich ananotherapeuticstrategytotargetdrugtolerantcellsandovercomeegfrtyrosinekinaseinhibitorresistanceinlungcancer AT mukundseshadri ananotherapeuticstrategytotargetdrugtolerantcellsandovercomeegfrtyrosinekinaseinhibitorresistanceinlungcancer AT yunwu ananotherapeuticstrategytotargetdrugtolerantcellsandovercomeegfrtyrosinekinaseinhibitorresistanceinlungcancer AT pamelaannehershberger ananotherapeuticstrategytotargetdrugtolerantcellsandovercomeegfrtyrosinekinaseinhibitorresistanceinlungcancer AT tatianashaurova nanotherapeuticstrategytotargetdrugtolerantcellsandovercomeegfrtyrosinekinaseinhibitorresistanceinlungcancer AT lingyueyan nanotherapeuticstrategytotargetdrugtolerantcellsandovercomeegfrtyrosinekinaseinhibitorresistanceinlungcancer AT yafeisu nanotherapeuticstrategytotargetdrugtolerantcellsandovercomeegfrtyrosinekinaseinhibitorresistanceinlungcancer AT lauriejamesrich nanotherapeuticstrategytotargetdrugtolerantcellsandovercomeegfrtyrosinekinaseinhibitorresistanceinlungcancer AT vuikingvincentchong nanotherapeuticstrategytotargetdrugtolerantcellsandovercomeegfrtyrosinekinaseinhibitorresistanceinlungcancer AT hannahcalkins nanotherapeuticstrategytotargetdrugtolerantcellsandovercomeegfrtyrosinekinaseinhibitorresistanceinlungcancer AT saraswatipokharel nanotherapeuticstrategytotargetdrugtolerantcellsandovercomeegfrtyrosinekinaseinhibitorresistanceinlungcancer AT martinpetkovich nanotherapeuticstrategytotargetdrugtolerantcellsandovercomeegfrtyrosinekinaseinhibitorresistanceinlungcancer AT mukundseshadri nanotherapeuticstrategytotargetdrugtolerantcellsandovercomeegfrtyrosinekinaseinhibitorresistanceinlungcancer AT yunwu nanotherapeuticstrategytotargetdrugtolerantcellsandovercomeegfrtyrosinekinaseinhibitorresistanceinlungcancer AT pamelaannehershberger nanotherapeuticstrategytotargetdrugtolerantcellsandovercomeegfrtyrosinekinaseinhibitorresistanceinlungcancer |